Project Grant R01DE034695
Award Date
4/9/25
Completion Date
3/31/30
Dollars Obligated
$476K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This $429,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will fund research on differential responses of jawbone versus long bone cells to bone growth factor signaling and mechanical loading. The research aims to provide novel molecular insights into unique mechanisms governing jawbone health, with the goal of improving physical and pharmacological interventions for...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), totaling $557,606.00, supports research aimed at advancing the understanding of periodontal stem cells and their regulation for more predictable and efficient periodontal tissue regeneration. The key research objectives are to: 1) characterize the properties of periodontal crestal stem cells (PCSCs) and their activation by...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totals $588,952 and will run from April 2025 to March 2030. The funding will support the development and optimization of a bio-inspired tubular matrix scaffold to guide the formation of periodontal ligament (PDL) principal fibers and rebuild the microenvironment for the regeneration of Sharpey's fibers, which are critical for...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides funding to Cayman Chemical Co Inc. to develop novel small molecule pharmacotherapies that can stimulate alveolar bone regeneration for dental applications. The $306,868 grant, awarded on April 8, 2025, with a completion date of April 7, 2026, aims to create EZH2 inhibitor compounds that can induce osteogenesis and...
This $675,684 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will fund a two-year research project at the University of Michigan to investigate the microbial ecosystem and host interactions around dental implants. The goal is to improve understanding of how this ecosystem develops, becomes unbalanced, and leads to peri-implantitis, a common inflammatory condition that...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), provides $109,548.00 to the University of Alabama at Birmingham to support research on the role of the RUNX2 transcription factor in postnatal dentin synthesis and alveolar bone formation. The research aims to elucidate the regulatory mechanisms by which RUNX2 governs dentin and alveolar bone development, with...
This federal Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate a novel regulator, DIN, that governs the regenerative capacity of murine teeth. The $346,938 award, with a performance period from September 12, 2024 to August 31, 2029, aims to determine DIN's role in regulating mesenchymal stem cell (MSC) homeostasis during tissue turnover and...
This Project Grant award of $565,228, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program, aims to identify cell surface markers and develop strategies for harnessing periodontal ligament stem cells (PDLSCs) to induce endogenous periodontal regeneration. The research, conducted by the University of Pittsburgh from August 2024 to May 2029, seeks to characterize the human homologs of mouse...
This federal Project Grant award of $513,574.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant will fund research to elucidate the mechanisms and genetic factors that contribute to the development of osteonecrosis of the jaw (ONJ), a debilitating condition affecting patients taking anti-resorptive medications like bisphosphonates. The research aims to identify key cellular...
This federal Project Grant award of $499,105 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop a novel miRNA-based therapeutic to enhance bone regeneration and suppress bone resorption for advanced oral squamous cell carcinoma (OSCC) patients. The key products and services to be delivered include: Determining the functions of miR-200c in promoting mandibular bone regeneration under...